Overview

Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone

Status:
Recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
Adult subjects with elevated intraocular pressure who have successfully undergone placement of iStent infinite trabecular bypass system will be randomized to receive a travoprost intraocular implant or receive a sham procedure and be followed for 12 months.
Phase:
Phase 3
Details
Lead Sponsor:
Glaukos Corporation
Treatments:
Travoprost